World professional association for transgender health's standards of care requirements of hormone therapy for adults with gender identity disorder

Walter Meyer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hormone therapy is one of the major steps in the transition from one gender to the other. The influence of hormones is profound and they change body image significantly. For an individual to begin hormone therapy, he/she needs to meet specific eligibility and readiness criteria that include taking other social/personal steps toward transition to the new gender and developing a thorough understanding of the medical and social risks and benefits of sex hormones. There are very few studies examining these specific eligibility and readiness criteria. However using these criteria, the long-term outcomes of individuals undergoing transition have improved since the establishment of the criteria in the SOC in 1980. Several specific questions are not addressed in the current Standards of Care (SOC). (1) Is there a role for blocking sex hormones in these adults as there is in adolescents? Some transgender individuals are focused on getting rid of endogenous sex hormones and their effects such as menstruation. They initially are not interested in the cross sex hormones, but are interested in hormone blockers. (2) Is it appropriate to prescribe cross-sex hormones for individuals who do not desire to have sex-reassignment surgery? Some transgender individuals are happy and content with hormone therapy alone. (3) Is there a role for a hormone-treatment test? The early SOC acknowledged its usefulness but subsequent versions have not addressed the issue. There is essentially no published data on these issues. More studies are definitely needed to examine when the sex hormone therapy should be used and the form it should take.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalInternational Journal of Transgenderism
Volume11
Issue number2
DOIs
StatePublished - 2009

Fingerprint

professional association
gender
health
menstruation
body image
surgery
adolescent

Keywords

  • Gender
  • Gender identity disorder
  • Hormones
  • Sex
  • Transgendered
  • Transsexualism

ASJC Scopus subject areas

  • Gender Studies

Cite this

@article{e302f460469f42a5952c846e08603e2d,
title = "World professional association for transgender health's standards of care requirements of hormone therapy for adults with gender identity disorder",
abstract = "Hormone therapy is one of the major steps in the transition from one gender to the other. The influence of hormones is profound and they change body image significantly. For an individual to begin hormone therapy, he/she needs to meet specific eligibility and readiness criteria that include taking other social/personal steps toward transition to the new gender and developing a thorough understanding of the medical and social risks and benefits of sex hormones. There are very few studies examining these specific eligibility and readiness criteria. However using these criteria, the long-term outcomes of individuals undergoing transition have improved since the establishment of the criteria in the SOC in 1980. Several specific questions are not addressed in the current Standards of Care (SOC). (1) Is there a role for blocking sex hormones in these adults as there is in adolescents? Some transgender individuals are focused on getting rid of endogenous sex hormones and their effects such as menstruation. They initially are not interested in the cross sex hormones, but are interested in hormone blockers. (2) Is it appropriate to prescribe cross-sex hormones for individuals who do not desire to have sex-reassignment surgery? Some transgender individuals are happy and content with hormone therapy alone. (3) Is there a role for a hormone-treatment test? The early SOC acknowledged its usefulness but subsequent versions have not addressed the issue. There is essentially no published data on these issues. More studies are definitely needed to examine when the sex hormone therapy should be used and the form it should take.",
keywords = "Gender, Gender identity disorder, Hormones, Sex, Transgendered, Transsexualism",
author = "Walter Meyer",
year = "2009",
doi = "10.1080/15532730903008065",
language = "English (US)",
volume = "11",
pages = "127--132",
journal = "International Journal of Transgenderism",
issn = "1434-4599",
publisher = "Haworth Press Inc.",
number = "2",

}

TY - JOUR

T1 - World professional association for transgender health's standards of care requirements of hormone therapy for adults with gender identity disorder

AU - Meyer, Walter

PY - 2009

Y1 - 2009

N2 - Hormone therapy is one of the major steps in the transition from one gender to the other. The influence of hormones is profound and they change body image significantly. For an individual to begin hormone therapy, he/she needs to meet specific eligibility and readiness criteria that include taking other social/personal steps toward transition to the new gender and developing a thorough understanding of the medical and social risks and benefits of sex hormones. There are very few studies examining these specific eligibility and readiness criteria. However using these criteria, the long-term outcomes of individuals undergoing transition have improved since the establishment of the criteria in the SOC in 1980. Several specific questions are not addressed in the current Standards of Care (SOC). (1) Is there a role for blocking sex hormones in these adults as there is in adolescents? Some transgender individuals are focused on getting rid of endogenous sex hormones and their effects such as menstruation. They initially are not interested in the cross sex hormones, but are interested in hormone blockers. (2) Is it appropriate to prescribe cross-sex hormones for individuals who do not desire to have sex-reassignment surgery? Some transgender individuals are happy and content with hormone therapy alone. (3) Is there a role for a hormone-treatment test? The early SOC acknowledged its usefulness but subsequent versions have not addressed the issue. There is essentially no published data on these issues. More studies are definitely needed to examine when the sex hormone therapy should be used and the form it should take.

AB - Hormone therapy is one of the major steps in the transition from one gender to the other. The influence of hormones is profound and they change body image significantly. For an individual to begin hormone therapy, he/she needs to meet specific eligibility and readiness criteria that include taking other social/personal steps toward transition to the new gender and developing a thorough understanding of the medical and social risks and benefits of sex hormones. There are very few studies examining these specific eligibility and readiness criteria. However using these criteria, the long-term outcomes of individuals undergoing transition have improved since the establishment of the criteria in the SOC in 1980. Several specific questions are not addressed in the current Standards of Care (SOC). (1) Is there a role for blocking sex hormones in these adults as there is in adolescents? Some transgender individuals are focused on getting rid of endogenous sex hormones and their effects such as menstruation. They initially are not interested in the cross sex hormones, but are interested in hormone blockers. (2) Is it appropriate to prescribe cross-sex hormones for individuals who do not desire to have sex-reassignment surgery? Some transgender individuals are happy and content with hormone therapy alone. (3) Is there a role for a hormone-treatment test? The early SOC acknowledged its usefulness but subsequent versions have not addressed the issue. There is essentially no published data on these issues. More studies are definitely needed to examine when the sex hormone therapy should be used and the form it should take.

KW - Gender

KW - Gender identity disorder

KW - Hormones

KW - Sex

KW - Transgendered

KW - Transsexualism

UR - http://www.scopus.com/inward/record.url?scp=72849124728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72849124728&partnerID=8YFLogxK

U2 - 10.1080/15532730903008065

DO - 10.1080/15532730903008065

M3 - Article

AN - SCOPUS:72849124728

VL - 11

SP - 127

EP - 132

JO - International Journal of Transgenderism

JF - International Journal of Transgenderism

SN - 1434-4599

IS - 2

ER -